HT treatment with estrogens alone or in combination with progestogens was associated with a small to moderate improvement in sexual function , particularly in pain , when used in women with menopausal symptoms or in early postmenopause ( within five years of amenorrhoea ) , but not in unselected postmenopausal women .
The current evidence does not suggest an important effect of tibolone or of SERMs alone or combined with estrogens on sexual function .
BACKGROUND The perimenopausal and postmenopausal periods are associated with many symptoms , including sexual complaints .
OBJECTIVES To assess the effect of hormone therapy ( HT ) on  sexual function in perimenopausal and postmenopausal women .
Some clinical effects of oestrogen-progestogen therapy in surgically castrated women.
This study reports some of the effects of oestrogen and progestogen therapy .  forty-nine women who had undergone hysterectomy and bilateral salpingo-oophorectomy took part in a double blind crossover study during which they received ethinyl oestradiol 50 micrograms/day , norgestrel 250 micrograms/day , the combination of these substances " Nordiol " and placebo .  Somatic complaints were assessed at monthly interviews and weight and blood pressure recorded . The addition of norgestrel to ethinyl oestradiol therapy result ed in less dryness of skin but significantly increased mastalgia and breast size . There were no significant differences between drugs on amount of facial hair , acne , arthralgia , pruritus vulvae , vaginal discharge , vaginal odour , dyspareunia , weight or blood pressure . There was a significant reduction of diastolic blood pressure with the time duration of the study
HT treatment with estrogens alone or in combination with progestogens was associated with a small to moderate improvement in sexual function , particularly in pain , when used in women with menopausal symptoms or in early postmenopause ( within five years of amenorrhoea ) , but not in unselected postmenopausal women .
The current evidence does not suggest an important effect of tibolone or of SERMs alone or combined with estrogens on sexual function .
BACKGROUND The perimenopausal and postmenopausal periods are associated with many symptoms , including sexual complaints .
OBJECTIVES To assess the effect of hormone therapy ( HT ) on  sexual function in perimenopausal and postmenopausal women .